• Participants
  • Career opportunities
  • Contact us
  • FIN
  • EST
  • RUS
  • SWE
  • NEP
  • CHN

logo


  • About
    • Objectives
    • Expected Results
  • Structure
  • Training
  • Ethics
  • Events
  • Publications
  • Exploitation of the results and IPR issues
facebook


Publications

  • We have recently published a peer-review article on GDNF mimetics in pain: Sidorova et al., 2017. A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat. Front. Pharmacol., 21 June 2017, Volume 8, Article 365, https://doi.org/10.3389/fphar.2017.00365 (link: http://journal.frontiersin.org/article/10.3389/fphar.2017.00365/full)
    We have also published a paper on a preprint server called BioRxiv. Bespalov et al., 2016. Novel agonist of GDNF family ligand receptor RET for the treatment of experimental neuropathy. BioRxiv. doi: https://doi.org/10.1101/061820. (link: http://www.biorxiv.org/content/early/2016/07/04/061820)
  • Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson’s disease
  • The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signaling and heparin binding

News

  • Annual newsletter no. 4 (01.11.2017) 04/12/2017
  • Scientific achievements during 3rd year of the project 15/05/2017
  • Annual newsletter no. 2 (20.4.2016) 05/08/2016

Links

  • Molcode Ltd.
  • University of Helsinki (UoH)
    • Institute of Biotechnology
    • Faculty of Pharmacy